home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

1,036 rows where filing_year = 2017 and issue_code = "PHA" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, is_termination, received_date (date)

filing_period 4

  • fourth_quarter 270
  • third_quarter 265
  • first_quarter 259
  • second_quarter 242

issue_code 1

  • PHA · 1,036 ✖

filing_year 1

  • 2017 · 1,036 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
1947947 AMERICAN SOCIETY OF CONSULTANT PHARMACISTS 3a5f3f0b-5635-436e-a648-cff95fb295bb Q1 AMERICAN SOCIETY OF CONSULTANT PHARMACISTS 3446 AMERICAN SOCIETY OF CONSULTANT PHARMACISTS 2017 first_quarter PHA Pharmacy provider status Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   40000 0 0 2017-03-24T14:26:46.610000-04:00
1948142 QGA PUBLIC AFFAIRS (FORMERLY QUINN GILLESPIE & ASSOCIATES) 8c772158-223b-40bb-801b-ecac4510e90e 1T QGA PUBLIC AFFAIRS (FORMERLY QUINN GILLESPIE & ASSOCIATES) 54197 NEKTAR THERAPEUTICS 2017 first_quarter PHA FDA oversight of certain pain-reliever products HOUSE OF REPRESENTATIVES,SENATE 60000   0 1 2017-04-01T13:25:56.923000-04:00
1948252 AMERICAN AMBULANCE ASSOCIATION fd64d611-e2d9-4c18-8eaa-650a5d80dd79 Q1 AMERICAN AMBULANCE ASSOCIATION 56018 AMERICAN AMBULANCE ASSOCIATION 2017 first_quarter PHA Lobbied for passage of Protecting Patient Access to Emergency Medication Act (H.R. 304). Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   280000 0 0 2017-04-03T08:16:32.013000-04:00
1948523 KATE MOSS 151a9b1a-0e47-415a-9866-36ca4445b2ef Q1 KATE MOSS 25988 CVS HEALTH 2017 first_quarter PHA Legislation impacting PBMs and drug pricing HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2017-04-04T11:59:42.157000-04:00
1948600 AMERICAN COLLEGE OF CLINICAL PHARMACY 3cbb2c51-8b95-4552-98aa-c628f477201d Q1 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2017 first_quarter PHA Coverage for direct patient care services of qualified pharmacists under Medicare and other public health programs. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   128375 0 0 2017-04-04T14:35:58.480000-04:00
1948773 RED+BLUE STRATEGIES b38b497b-7287-45b6-bcb8-6eeb203d38a3 Q1 RED+BLUE STRATEGIES 400693064 EXPRESS SCRIPTS INC. 2017 first_quarter PHA S. Con. Res. 3 - Budget Resolution for FY2017 - Impact of reconciliation instructions on the prescription drug benefit and coverage for those covered through health care market places and Medicaid beneficiaries. S. 637 - Creating Transparency to have Prescription Drug Rebates Unlocked - Issues related to the alleged relationship between rebates and drug prices. S. 771 - A bill to Improve Access to Affordable Prescription Drugs - Issue related to bringing drug pricing down including better policies in the Part D coverage gap, couponing and advancing biosimilars. Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2017-04-05T11:14:18.410000-04:00
1948852 RED+BLUE STRATEGIES 24e25b3f-6938-4788-be6d-38a3df976712 Q1 RED+BLUE STRATEGIES 400693064 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) 2017 first_quarter PHA S. Con. Res. 3 - Budget Resolution for FY 2017 - Impact of reconciliation instructions on the prescription drug benefit and coverage for those covered through health care marketplaces and Medicaid beneficiaries. S. 637 - Creating Transparency to Have Prescription Drug Rebates Unlocked - Issues related to the alleged relationship between rebates and drug prices. S. 771 - A Bill to Improve Access to Affordable Prescription Drugs - Issues related to bringing drug prices down including strengthening policies in the Part D coverage gap, couponing and advancing biosimilars. Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2017-04-05T14:34:39.670000-04:00
1948863 RED+BLUE STRATEGIES 76f42342-654b-4454-a97d-bb971b0eeba0 Q1 RED+BLUE STRATEGIES 400693064 PEW CHARITABLE TRUSTS 2017 first_quarter PHA Issues related to antibiotic innovation and advancement Issues related opioid abuse and methods to fight against the opioid epidemic in the United States. Issues related to ensuring the safety of compounded medications. Issues related to over the counter medications and supplements. Issues related to the Physician Payment Sunshine Act and the Open Payments system. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2017-04-05T14:53:49.380000-04:00
1948873 AMERICAN CAPITOL GROUP c0d7ddce-5a0c-45a1-9725-04e6027dc510 Q1 AMERICAN CAPITOL GROUP 305852 CARDINAL HEALTH 2017 first_quarter PHA Issues Related to Distribution and Sale of Pharmaceutical and Medical Products and Services; HOUSE OF REPRESENTATIVES,SENATE 25000   0 0 2017-04-05T15:09:55.747000-04:00
1949345 WAXMAN STRATEGIES ad673291-e103-44f0-a9de-5dd10675ebd8 Q1 WAXMAN STRATEGIES 401103693 340B HEALTH 2017 first_quarter PHA Issues affecting the 340B drug pricing program HOUSE OF REPRESENTATIVES 18750   0 0 2017-04-07T14:48:44.613000-04:00
1950336 HOLLAND & KNIGHT LLP f757043d-43c2-4a6a-90e9-8822c87fd08c Q1 HOLLAND & KNIGHT LLP 18466 PROTECTING ACCESS TO PAIN RELIEF COALITION 2017 first_quarter PHA Advocating for policy to ensure patient access to pain relief.   50000   0 0 2017-04-11T14:56:58.060000-04:00
1950342 HOLLAND & KNIGHT LLP 045ae1f1-0879-4755-aa32-94e444ff899d Q1 HOLLAND & KNIGHT LLP 18466 THE BIOSIMILARS FORUM 2017 first_quarter PHA Medicare reimbursement issues, FDA regulation of biosimilars. HOUSE OF REPRESENTATIVES,SENATE 120000   0 0 2017-04-11T15:02:07.023000-04:00
1950374 FLYNN & ASSOCIATES, INC. 331d86e1-153f-443d-ab2d-46c7df3068e6 Q1 FLYNN & ASSOCIATES, INC. 15020 PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION 2017 first_quarter PHA PDUFA Reauthorization Importation of drugs from overseas HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2017-04-11T15:12:27.110000-04:00
1950440 PARRY, ROMANI, DECONCINI & SYMMS e3407194-3390-4035-a76e-fe4fa0d902e3 Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 ROCK & ASSOCIATES 2017 first_quarter PHA Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. HOUSE OF REPRESENTATIVES,SENATE 12000   0 0 2017-04-11T15:52:17.723000-04:00
1951084 KNIGHT CAPITOL CONSULTANTS a6f118e1-e45a-472a-8c01-0a686f6a6674 Q1 KNIGHT CAPITOL CONSULTANTS 40036301 EQUASHIELD, LLC 2017 first_quarter PHA Monitor issues related to Medical Device User Fee Act reauthorization (no bill yet) HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2017-04-12T14:28:26.520000-04:00
1951147 AMERICAN PHARMACISTS ASSOCIATION 3d79f8a0-3285-4d2c-a149-0d7e2b0db7ec 1A AMERICAN PHARMACISTS ASSOCIATION 3071 AMERICAN PHARMACISTS ASSOCIATION 2017 first_quarter PHA HR 1038, S 413 Improving Transparency and Accuracy in Medicare Part D Spending Act HR 1939 To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes. HR 592, S 109 To amend title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services. HR 1480 Safe and Affordable Drugs from Canada Act of 2017 S 637 Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017 HR 1586 To amend the Federal Food, Drug, and Cosmetic Act to ensure that liquid over-the-counter medications are packaged with appropriate dosage delivery devices and, in the case of such medications labeled for pediatric use, appropriate flow restrictors, and for other purposes. S 778 Prescription Drug Monitoring Act of 2017 HR 934 Personal Drug Importation Fairness Act of 2017 HR 421 Allowing Greater Access to Safe and Effective Contraception Act HR 1436 To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. HR 1245, S 469 To amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals. HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2017-04-12T15:13:53.620000-04:00
1951148 MR. VINCENT A. PANVINI 48d8bbf6-fc2a-4612-83b6-89fa36ba3131 Q1 MR. VINCENT A. PANVINI 401008845 PHRMA 2017 first_quarter PHA Importation of Pharmaceuticals HOUSE OF REPRESENTATIVES,SENATE     0 0 2017-04-12T15:15:54.700000-04:00
1951255 INDEPENDENT PHARMACY COOPERATIVE 6eba9c9f-f1a5-4fd1-bfe8-398c75ec6806 Q1 INDEPENDENT PHARMACY COOPERATIVE 313098 INDEPENDENT PHARMACY COOPERATIVE 2017 first_quarter PHA Support S. 109/H.R. 592, the Pharmacy and Medically Underserved Areas Enhancement Act Support S.413/H.R. 1038, the "Improving Transparency and Accuracy in Medicare Part D Drug Spending Act. Ensure patient choice in Comprehensive Addiction and Recovery Act of 2016 lock-in provision. Support Affordable Care Act of 2010 Average Manufacturer Price methodology. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2017-04-12T17:25:09.533000-04:00
1951324 DAVE KOLBE CONSULTING 2959c074-d9b5-497b-b6d4-0721014af51d Q1 DAVE KOLBE CONSULTING 401104329 PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION 2017 first_quarter PHA Medicare Part-D rebates Trade agreements Patent reform issues HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2017-04-12T20:56:23.747000-04:00
1951396 MCDERMOTT+ LLC 7b61d06e-57a6-4167-ab82-9ea7ec3d5f6c Q1 MCDERMOTT+ LLC 401103287 ALLIANCE FOR RURAL HOSPITAL ACCESS 2017 first_quarter PHA Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2017-04-13T09:40:44.973000-04:00
1952218 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION e63c7e03-0f7c-47dc-8688-49303a7e3e8c Q1 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION 31348 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION 2017 first_quarter PHA Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks. Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, Direct and Indirect Remuneration (DIR), pharmacy networks, and mail-service pharmacy. Issues related to the management of Medicaid prescription drug benefits. Issues related to prescription drug abuse. Provisions of PL 111-148 and PL 111-152 impacting Medicare Part D such as PBM disclosure provisions, implementation of the prescriber registration rules and definition of negotiated price. HR.1038/S.413, Improving Transparency and Accuracy in Part D Spending Act H.R.1316, Prescription Drug Price Transparency Act S.637, Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017 S.771, Improving Access to Affordable Prescription Drug Act Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),SENATE 693081   0 0 2017-04-13T14:52:58.190000-04:00
1952237 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION 361d12de-0b0e-4102-8c54-e120fbb2f86b 1A PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION 31348 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION 2017 first_quarter PHA Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks. Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, Direct and Indirect Remuneration (DIR), pharmacy networks, and mail-service pharmacy. Issues related to the management of Medicaid prescription drug benefits. Issues related to prescription drug abuse. Provisions of PL 111-148 and PL 111-152 impacting Medicare Part D such as PBM disclosure provisions, implementation of the prescriber registration rules and definition of negotiated price. HR.1038/S.413, Improving Transparency and Accuracy in Part D Spending Act H.R.1316, Prescription Drug Price Transparency Act S.637, Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017 S.771, Improving Access to Affordable Prescription Drug Act Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),SENATE   693081 0 0 2017-04-13T15:01:15.737000-04:00
1952608 MR. GALEN RESER dd12a8a9-560f-49f7-8d46-1dea22ada7f0 Q1 MR. GALEN RESER 401055978 PERRIGO INC (THROUGH FTI GOVERNMENT AFFAIRS) 2017 first_quarter PHA Repeals a requirement enacted into law as part of the PPACA of 2010 that requires consumers to obtain a prescription in order to utilize their FSAs and HSAs to purchase over-the-counter OTC medicines. FDA's proposed changes to generic drug labeling. House Energy and Commerce 21st Century Cures Initiative. Senate Health, Education, Labor and Pensions 21st Century Cures Initiative. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2017-04-13T18:51:00.003000-04:00
1952863 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 14ca0a61-8104-453a-8b0d-0f4694497b27 Q1 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 3457 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 2017 first_quarter PHA Contact concerning FDA authority to manage drug shortages, regulation of pharmacy compounding, implementation of the Drug Quality and Security Act. Communication with FDA on Generic Drug User Fee Act, Prescription Drug user Fee Act, Biosimilar User Fee Act, and electronic drug information. Contact on manufacturing gaming REMS to gain market advantage Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE   260000 0 0 2017-04-14T11:51:18.753000-04:00
1953307 MR. BRIAN KELLY 8ca8e27c-24ac-4198-a085-8a70c6dddfc4 Q1 MR. BRIAN KELLY 40024191 LUNDBECK PHARMACEUTICALS 2017 first_quarter PHA CNS Brain Disorders Alzheimer's HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2017-04-14T17:36:52.507000-04:00
1953326 THE D MAJOR GROUP abb6b468-42ec-4880-99e2-f9ce83da8072 Q1 THE D MAJOR GROUP 401103162 CVS CAREMARK 2017 first_quarter PHA Advocate for the protection of pharmaceutical benefit management and resulting cost savings. HOUSE OF REPRESENTATIVES,SENATE 34500   0 0 2017-04-14T18:34:11.717000-04:00
1953521 POLITICAL CAPITAL, LLC 271ca983-3e80-4ab3-9240-0b90dacfad1a Q1 POLITICAL CAPITAL, LLC 401104260 MEDISCA INC 2017 first_quarter PHA DQSA Oversight Food & Drug Administration (FDA) 15000   0 0 2017-04-16T17:08:04.573000-04:00
1953530 APOTEX CORP. 734c605d-a7a9-4a99-892e-643ba9086316 Q1 APOTEX CORP. 310973 APOTEX CORP. 2017 first_quarter PHA Federal policy relating to the reauthorization of the Generic Drug User Fee Act; Federal policy relating to the cost of prescription pharmaceuticals; Federal policy relating to the provision of brand drug products by brand manufacturers to generic manufacturers for development testing, and for shared Risk Evaluation and Mitigation (REMS) programs for brand and generic pharmaceuticals; HR 749, the Lower Drug Costs Through Competition Act, provisions relating to priority review vouchers for and expedited approval of certain generic drug applications, and Risk Evaluation and Mitigation (REMS) programs; and Draft legislation (no bill number) related to generic drug exclusivity and the review of Abbreviated New Drug Applications (ANDAs). HOUSE OF REPRESENTATIVES,SENATE   160000 0 0 2017-04-16T21:04:18.540000-04:00
1953557 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION b8d33cee-8c47-4ddf-932a-a95c6a016575 Q1 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 27478 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 2017 first_quarter PHA Congressional Oversight of 340 B Program; Issues related to FDA implementation of The Drug Quality and Security Act related to the regulations of pharmacy compounding; Biosimilar naming; H.R. 421 Allowing Greater Access to Safe and Effective Contraception Act Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),Office of Natl Drug Control Policy (NDCP),Office of Personnel Management (OPM),SENATE,White House Office   370000 0 0 2017-04-17T08:10:36.257000-04:00
1953667 ROCK & ASSOCIATES 2cd6cbc2-8c9a-4f96-86ec-af6925c50817 Q1 ROCK & ASSOCIATES 33545 BRAIDWOOD MANAGEMENT, INC. 2017 first_quarter PHA Issues pertaining to pharmacy compounding. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2017-04-17T09:24:19.837000-04:00
1953675 ROCK & ASSOCIATES 47553295-eaf6-46ed-b294-68539bce3e68 Q1 ROCK & ASSOCIATES 33545 DIAMONDBACK DRUGS 2017 first_quarter PHA Legislation pertaining to pharmacy compounding. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2017-04-17T09:27:26.073000-04:00
1953685 ROCK & ASSOCIATES f8e490b8-fda8-43e7-8504-44b39576b42c Q1 ROCK & ASSOCIATES 33545 VETERINARY PHARMACIES OF AMERICA, INC. 2017 first_quarter PHA Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2017-04-17T09:28:31.417000-04:00
1953691 ROCK & ASSOCIATES 46926c7a-0072-4872-a1b5-9e857830b0ac Q1 ROCK & ASSOCIATES 33545 WEDGEWOOD VILLAGE PHARMACY, INC. 2017 first_quarter PHA Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2017-04-17T09:29:36.747000-04:00
1953698 ROCK & ASSOCIATES c735433b-6eb2-4c0a-acb4-907c7c496031 Q1 ROCK & ASSOCIATES 33545 WOMEN'S INTERNATIONAL PHARMACY 2017 first_quarter PHA Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2017-04-17T09:31:43.450000-04:00
1953701 ROCK & ASSOCIATES b1c16673-0995-478c-81f8-ce717dcf2d25 Q1 ROCK & ASSOCIATES 33545 WELLNESS PHARMACY 2017 first_quarter PHA Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2017-04-17T09:31:44.557000-04:00
1954373 NELSON MULLINS RILEY & SCARBOROUGH 62c12396-9bf4-4542-bfc7-dd52ead0e0be Q1 NELSON MULLINS RILEY & SCARBOROUGH 285871 CASCADE HEMOPHILIA CONSORTIUM 2017 first_quarter PHA Issues related to 340B Drug Pricing Program HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2017-04-17T14:31:54.937000-04:00
1954386 NELSON MULLINS RILEY & SCARBOROUGH 41a088e8-5f3d-4db9-982d-2001ab16feaf Q1 NELSON MULLINS RILEY & SCARBOROUGH 285871 HEMOPHILIA OF GEORGIA 2017 first_quarter PHA Issues related to the 340B Drug Pricing Program and the proposed American Health Care Act HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2017-04-17T14:34:01.767000-04:00
1954409 RED+BLUE STRATEGIES 78848480-fcbd-4ad1-ba62-74ce476e955b Q1 RED+BLUE STRATEGIES 400693064 BLUE CROSS BLUE SHIELD OF MASSACHUSETTS 2017 first_quarter PHA Issues related to curbing the abuse of opioids in the United States. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2017-04-17T14:39:22.313000-04:00
1954492 RED+BLUE STRATEGIES 36235c2e-6b77-425e-8624-9ab1abeaf601 Q1 RED+BLUE STRATEGIES 400693064 COHERUS BIOSCIENCES 2017 first_quarter PHA S. 771 - A bill to improve access to affordable prescription drugs - issues related to ensuring a healthy market for biosimilar medications. Issues related to the upcoming biosimilars User Fee Agreement legislation. Issues related to the treatment of biosimilar medications in Medicare Part B and D programs. Issues related to the maintenance of current IPR laws. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2017-04-17T15:01:23.567000-04:00
1954512 MERCURY PUBLIC AFFAIRS, LLC 5f9132a5-dbd2-4e34-9f54-6f7add896501 Q1 MERCURY PUBLIC AFFAIRS, LLC 70175 KALISPELL REGIONAL HEALTHCARE 2017 first_quarter PHA Veteran pharmacy issues and polices Federal Communications Commission (FCC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) 30000   0 0 2017-04-17T15:06:39.097000-04:00
1954618 DENTONS US LLP 2ac27f6b-9216-469f-a84c-c5d47fcae34a Q1 DENTONS US LLP 36105 PHRMA 2017 first_quarter PHA Any federal issues regarding the research and development of pharmaceuticals       0 0 2017-04-17T15:28:40.757000-04:00
1955107 BROYDRICK & ASSOCIATES a6b71256-4916-4bd9-abd0-f2b4bd32850e Q1 BROYDRICK & ASSOCIATES 7268 TONIX PHARMACEUTICALS 2017 first_quarter PHA Funding for a new drug for PTSD. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2017-04-17T20:13:18.170000-04:00
1955249 THORN RUN PARTNERS 1b5f222e-b07d-4acd-88e9-3ccdac3035a6 Q1 THORN RUN PARTNERS 400534596 EXPRESS SCRIPTS, INC. 2017 first_quarter PHA Pharmacy benefits manager standards under the Medicare prescription drug program to further transparency of payment methodologies to pharmacies. Issues related to a pilot program in TRICARE that would establish Department of Defense (DoD) acquisition cost parity for prescription drugs obtained at community pharmacies. Drug reimbursement and general pharmacy related issues. S.637, Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017; issues related to transparency of pharmacy benefit managers (PBMs). HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2017-04-17T23:43:39.820000-04:00
1955475 MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) 5b6d2656-c707-422f-9ddf-ac74a62bf754 Q1 MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) 400265214 MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) 2017 first_quarter PHA Pricing, shortages, and safety issues Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   250000 0 0 2017-04-18T09:43:29.367000-04:00
1955517 MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) beea3ce5-3441-4c8d-a1cc-9d48e0d2d639 1A MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) 400265214 MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) 2017 first_quarter PHA Pricing, shortages, and safety issues Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   139625 0 0 2017-04-18T09:55:00.087000-04:00
1955711 ANIMAL HEALTH INSTITUTE ed1a1120-d948-404e-90f8-f0aca18a48d7 Q1 ANIMAL HEALTH INSTITUTE 4037 ANIMAL HEALTH INSTITUTE 2017 first_quarter PHA Issues related to illegal drug manufacturing under the guise of pharmacy compounding; Issues related to the granting of Categorical Exclusions for animal health products. HOUSE OF REPRESENTATIVES,SENATE   35000 0 0 2017-04-18T10:51:41.640000-04:00
1955785 RAMPY NORTHRUP LLC c640a20c-2fd3-4ca6-841d-755e77b682e2 Q1 RAMPY NORTHRUP LLC 401103289 ACADEMY OF MANAGED CARE PHARMACY 2017 first_quarter PHA Dissemination of pharmacoeconomic information. Implementation of 21st Century Cures Act (P.L.114-255). HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2017-04-18T11:12:39.503000-04:00
1956048 BLUECROSS BLUESHIELD OF TENNESSEE 71171336-c561-44dc-9342-7f71fd0b4836 Q1 BLUECROSS BLUESHIELD OF TENNESSEE 6440 BLUECROSS BLUESHIELD OF TENNESSEE 2017 first_quarter PHA Precision Medicine Act; General Pharmacy Issues; Opioid Abuse; specialty drug pricing Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2017-04-18T12:11:56.280000-04:00
1956167 THE INGRAM GROUP LLC 8989da2f-fcf2-438f-82b7-1ea493abcba4 Q1 THE INGRAM GROUP LLC 400577737 ELI LILLY AND COMPANY 2017 first_quarter PHA General issues related to the biopharmaceutical and pharmaceutical industries including drug importation. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2017-04-18T12:35:17.753000-04:00
1956338 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 032a4cdd-cf0c-4478-ac62-85288a5bf24a Q1 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 28776 HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) 2017 first_quarter PHA Rx Pedigree (Public Law 113-54); Ensuring Patient Access and Effective Enforcement Act (Public Law 114-145); Prescription Drug Abuse - General issues related to Rx drug abuse; Importation of Prescription Drugs (S 469, S 771, HR 1776, HR 1245, HR 934, HR 1480, S 92, S 64), Implementation of Public Law 113-54 (DSCSA) Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   313000 0 0 2017-04-18T13:14:05.053000-04:00
1956553 MASSACHUSETTS MEDICAL SOCIETY 83b0ebb5-072b-446e-b802-9c26bc25f735 Q1 MASSACHUSETTS MEDICAL SOCIETY 23975 MASSACHUSETTS MEDICAL SOCIETY 2017 first_quarter PHA S. 771 - Improving Access to Affordable Prescription Drugs - Legislation that seeks to address prescription drug costs by increasing transparency and accountability, boosting access and affordability of key drugs, spurring innovation, and increasing choice and competition by allowing Medicare to negotiate the price of drugs, among other provisions. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   100000 0 0 2017-04-18T13:54:05.730000-04:00
1956602 ASCENSION HEALTH c17e2590-ab69-4e35-a676-8827d118cdd6 Q1 ASCENSION HEALTH 53301 ASCENSION HEALTH 2017 first_quarter PHA Drug pricing; Creating and Restoring Equal Access to Equivalent Samples Act of 2016 (CREATES) FAIR Drug Pricing Act Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   290000 0 0 2017-04-18T14:05:43.043000-04:00
1956950 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 807ff530-02b3-4010-9c22-0d89c6d61d6a Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 AMERICAN SOCIETY OF HEMATOLOGY 2017 first_quarter PHA HR 1409, Cancer Drug Coverage Parity Act Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2017-04-18T15:08:28.067000-04:00
1956973 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8d9dbba7-d018-472d-bff1-8e54332d02d2 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 THE HEMOPHILIA ALLIANCE 2017 first_quarter PHA Issues related to the 340B drug discount program Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2017-04-18T15:11:43.677000-04:00
1957010 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. a13e8a00-2924-49df-afd2-e589373cb016 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL HEMOPHILIA FOUNDATION 2017 first_quarter PHA Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing programs. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 50000   0 0 2017-04-18T15:17:10.600000-04:00
1957029 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 261b521b-05c5-4c21-9511-f88e948eb20a Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL ASSOCIATION OF EPILEPSY CENTERS 2017 first_quarter PHA Issues related to anti-epileptic drugs. Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 10000   0 0 2017-04-18T15:20:23.850000-04:00
1957104 FTI GOVERNMENT AFFAIRS 59ae3162-7ba9-4104-8528-451cdbb1fb73 Q1 FTI GOVERNMENT AFFAIRS 401054971 PERRIGO, INC. 2017 first_quarter PHA Repeals a requirement enacted into law as part of the PPACA of 2010 that requires consumers to obtain a prescription in order to utilize their FSA's and HSA's to purchase over-the-counter OTC medicines. FDA's proposed changes to generic drug labeling. House Energy and Commerce 21st Century Cures Initiative. Senate Health, Education, Labor and Pensions 21st Century Cures Initiative. HOUSE OF REPRESENTATIVES,SENATE 150000   0 0 2017-04-18T15:31:13.587000-04:00
1957209 THE MATHIS HARPLE GROUP 4486f685-3894-41bf-b39d-0fd88f8a78b8 Q1 THE MATHIS HARPLE GROUP 322911 PILMA 2017 first_quarter PHA Importation of Pharmaceuticals HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2017-04-18T15:45:11.010000-04:00
1957291 ACADEMY OF MANAGED CARE PHARMACY 30d251c2-4172-465d-9bb4-70472e247152 Q1 ACADEMY OF MANAGED CARE PHARMACY 48793 ACADEMY OF MANAGED CARE PHARMACY 2017 first_quarter PHA Supporting the dissemination of pharmacoeconomic information and urging Congress to continue its efforts against allowing substandard and dangerous counterfeit drugs to be imported across U.S. borders Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)   119000 0 0 2017-04-18T15:53:59.167000-04:00
1957341 FTI GOVERNMENT AFFAIRS e61cb369-47dc-4018-bc2a-bef975fb0779 Q1 FTI GOVERNMENT AFFAIRS 401054971 PROFESSIONAL COMPOUNDING CENTERS OF AMERICA 2017 first_quarter PHA Implementation of The Drug Quality and Security Act, H.R.3204 (Public Law) ((USP/NF Monograph)). HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2017-04-18T16:01:24.730000-04:00
1957369 NOVO NORDISK INC. 53915d13-a552-480a-a65b-4d0c2acf7c62 Q1 NOVO NORDISK INC. 284790 NOVO NORDISK INC. 2017 first_quarter PHA Issues related to Prescription Drug User Fee Act VI; issues related to 340B program; H.R. 1245/S. 469 Affordable and Safe Prescription Drug Importation Act Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),SENATE   1270000 0 0 2017-04-18T16:09:40.510000-04:00
1957383 EVERGREEN ASSOCIATES, LTD. be8aa1b6-6a96-426b-8b6f-a2702e66492e Q1 EVERGREEN ASSOCIATES, LTD. 13984 PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION 2017 first_quarter PHA - Docket ID: FDA-2007-N-0363: Electronic Distribution of Content of Labeling for Human Prescription Drug and Biological Product - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017, Prescription Drug labeling - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018, Prescription Drug labeling - FDA User Fees reauthorization (no bill) - Patient Medication Information HOUSE OF REPRESENTATIVES,SENATE     0 0 2017-04-18T16:11:50.683000-04:00
1957745 TARPLIN, DOWNS & YOUNG, LLC ced4b287-ffa2-4512-991e-61b4e21a6ff3 Q1 TARPLIN, DOWNS & YOUNG, LLC 304736 HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) 2017 first_quarter PHA Importation of prescription drugs (S. 469) Rx Pedigree (PL 113-54) Prescription Drug Monitoring Programs (S. 480, H.R. 1725) Prescription Drug Abuse - General issues related to Rx drug abuse Ensuring Patient Access and Effective Enforcement Act (PL 114-145) Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2017-04-18T17:36:35.023000-04:00
1957758 TRAVERE THERAPEUTICS ea3587aa-674c-4281-9cf3-ca45a0a64d9f Q1 TRAVERE THERAPEUTICS 401104190 TRAVERE THERAPEUTICS 2017 first_quarter PHA Orphan Drug Act, Drug Quality and Security Act, drug pricing, Prescription Drug User Fee Act reauthorization, FDA issues HOUSE OF REPRESENTATIVES,SENATE   140000 0 0 2017-04-18T17:38:39.677000-04:00
1958010 ISEMAN & ASSOCIATES LLC 43a811ee-0c0f-4659-89fa-605ef9da4d91 Q1 ISEMAN & ASSOCIATES LLC 401103582 TICHENOR VENTURES, LLC 2017 first_quarter PHA Monitoring biotech legislation HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2017-04-18T21:19:02.907000-04:00
1958073 WEST FRONT STRATEGIES LLC acbfda6a-8f5c-461c-85ab-30761e39bac1 Q1 WEST FRONT STRATEGIES LLC 401103493 WALGREEN CO. 2017 first_quarter PHA Pharmacy and Medically Underserved Areas Enhancement Act (S. 109 and HR 592), to amend Title IIX of the Social Security Act to allow pharmacists to be reimbursed under Medicare Part B for services provided to patients in medically underserved areas. HOUSE OF REPRESENTATIVES,SENATE,White House Office 60000   0 0 2017-04-18T22:05:50.100000-04:00
1958625 TARPLIN, DOWNS & YOUNG, LLC cb181d1b-0944-429c-b2d9-cac70a09cfa5 Q1 TARPLIN, DOWNS & YOUNG, LLC 304736 ASTRAZENECA 2017 first_quarter PHA PL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation PL 114-255 - 21st Century Cures, implementation ***, no specific bill(s), Import Safety, drug development policy, drug shortages, supply chain integrity, patent settlements, user fee reauthorization, Innovation Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2017-04-19T09:34:12.040000-04:00
1958739 TARPLIN, DOWNS & YOUNG, LLC 27ccdcf7-aab4-4b78-aa1c-e0a8c1a6c202 Q1 TARPLIN, DOWNS & YOUNG, LLC 304736 PHRMA 2017 first_quarter PHA PL 114-255 - 21st Century Cures, implementation H.R. 1628 - American Health Care Act of 2017 ***, no specific bill(s), prescription drug importation, import safety, supply chain integrity, Prescription Drug User Fee Act Fee Reauthorization and associated policies, user fee sequester, innovation Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2017-04-19T09:54:33.997000-04:00
1958885 SC PARTNERS LLC 08cff4a1-14ac-4c5e-af16-e708cf7bb240 Q1 SC PARTNERS LLC 318994 PFIZER, INC. 2017 first_quarter PHA Advocated for maintaining a safe prescription drug supply, and shared concerns about the safety and economic implications of allowing the importation of prescription drugs and biologics from Canada and other countries. Affordable and Safe Prescription Drug Importation Act (S. 469) HOUSE OF REPRESENTATIVES,SENATE 6000   0 0 2017-04-19T10:14:49.063000-04:00
1959162 CHAMBER HILL STRATEGIES a60d6279-1a18-4cb2-abbc-567c0181a2dc Q1 CHAMBER HILL STRATEGIES 400645947 AMAG PHARMACEUTICALS (FORMERLY KNOWN AS LUMARA PHARMACEUTICAL) 2017 first_quarter PHA Implementation issues related to P.L. 113-54, the Drug Quality and Security Act. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2017-04-19T10:46:46.533000-04:00
1960406 UNIVERSITY OF IOWA 0d00913e-87bf-4557-a2e2-b0009f6fae22 Q1 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2017 first_quarter PHA FY 17 and FY 18 appropriations for NIH Support for palliative care programs Administration for Children & Families (ACF),Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT)   86662 0 0 2017-04-19T13:22:00.943000-04:00
1960656 POWERS PYLES SUTTER & VERVILLE, P.C. ff1c2a20-2bf5-4648-96b0-0373601b3ec1 Q1 POWERS PYLES SUTTER & VERVILLE, P.C. 32008 340B HEALTH 2017 first_quarter PHA Section 340B of the Public Health Services Act, Section 1927 of the Social Security Act and issues related to (1) administration and Congressional oversight of the 340B Drug Discount Program, (2) implementation of 340B-related provisions in the Patient Protection and Affordable Care Act of 2010, and (3)finding of the Health Resources and Services Administration (HRSA) under the Labor Health & Human Services & education appropriations bills. HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2017-04-19T13:50:47.743000-04:00
1960756 LEHIGH VALLEY HEALTH NETWORK 4711e8f6-fbf3-4a82-ac94-57ca337c7053 Q1 LEHIGH VALLEY HEALTH NETWORK 40041332 LEHIGH VALLEY HEALTH NETWORK 2017 first_quarter PHA S.109 The Pharmacy and Medically Under-served Areas Enhancement Act HOUSE OF REPRESENTATIVES,SENATE     0 0 2017-04-19T13:59:45.387000-04:00
1960760 ALKERMES, INC. 42b8faaf-f373-4540-b783-daeadc1fdba1 Q1 ALKERMES, INC. 400458235 ALKERMES, INC. 2017 first_quarter PHA Public law #114-198, Cures Opioid Funding Implementation Reauthorization of the Prescription Drug User Fee Act (PDUFA) Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),Office of Natl Drug Control Policy (NDCP),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),Veterans Affairs, Dept of (VA)   920000 0 0 2017-04-19T14:00:47.760000-04:00
1960787 NATIONAL HOME INFUSION ASSOCIATION 46d3f622-d8f8-4f39-af56-5e32a3d1b7b8 Q1 NATIONAL HOME INFUSION ASSOCIATION 40047365 NATIONAL HOME INFUSION ASSOCIATION 2017 first_quarter PHA Compounding pharmacy regulation - worked to ensure DQSA (Pub L. 113-54) is being properly implemented, specifically the draft memorandum of understanding for 503 A pharmacies and FDA inspections of 503A pharmacies. Lobbied for the inclusion of Department of Agriculture/FDA appropriations language regarding inspection authority and scope of the draft memorandum of understanding Lobbied on proper inspections of 503A pharmacies Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   170000 0 0 2017-04-19T14:01:58.213000-04:00
1960994 ELI LILLY AND COMPANY 083f6602-cfe4-4f38-968e-899932dd0c2b Q1 ELI LILLY AND COMPANY 13392 ELI LILLY AND COMPANY 2017 first_quarter PHA Hospital discounts; 340B program Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR)   1390000 0 0 2017-04-19T14:16:42.823000-04:00
1961277 AMERICAN VETERINARY MEDICAL ASSOCIATION fbecfe50-1b45-49e4-9e1f-c5e79c3f8eae Q1 AMERICAN VETERINARY MEDICAL ASSOCIATION 3630 AMERICAN VETERINARY MEDICAL ASSOCIATION 2017 first_quarter PHA Discussions with Congressional staff and FDA to express the need for compounding of medications for use in animals and FDA's draft GFI #230 Discussions with DEA regarding use of controlled substances by veterinary practitioners, transportation of controlled substances, telemedicine and prescription monitoring programs. Discussions with Congressional staff about mandatory prescription writing for veterinarians. H.R. 623 Fairness to Pet Owners Act Veterinary Compounding Draft Legislation Agriculture, Dept of (USDA),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE   220000 0 0 2017-04-19T14:36:59.093000-04:00
1961288 ALLERGAN USA, INC. 9d16e355-16d6-4ce3-94fd-eb837c7f7b4b Q1 ALLERGAN USA, INC. 63837 ALLERGAN USA, INC. 2017 first_quarter PHA Ensuring the safety of the drug supply chain to protect patients and keep Americans safe. Drug Compounding. Drug Importation/Counterfeit Drugs. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE   1200000 0 0 2017-04-19T14:38:04.060000-04:00
1961313 MEHLMAN CONSULTING, INC. aea2a516-ca1a-4c0a-a063-921090ddb41d Q1 MEHLMAN CONSULTING, INC. 284950 FOOD ALLERGY RESEARCH & EDUCATION (FARE) 2017 first_quarter PHA Issues related to drug pricing. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2017-04-19T14:39:16.517000-04:00
1961413 TARPLIN, DOWNS & YOUNG, LLC ae5f1c96-4644-42b3-b647-5a6b4458bfbc Q1 TARPLIN, DOWNS & YOUNG, LLC 304736 BIOTECHNOLOGY INDUSTRY ORGANIZATION 2017 first_quarter PHA PL 114-255 - 21st Century Cures, implementation ***, no specific bill(s), Drug Safety, Prescription Drug Importation, Import Safety, supply chain integrity, biosimilars, PDUFA and associated policies, patent settlements, accelerated approval, break through therapies, compounding, user fee reauthorization, Innovation Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 80000   0 0 2017-04-19T14:50:16.327000-04:00
1961689 BUCHANAN INGERSOLL & ROONEY PC 14fa4fba-0444-4fa1-875a-8ced07b6d1bd Q1 BUCHANAN INGERSOLL & ROONEY PC 55291 BRECKENRIDGE PHARMACEUTICAL INC 2017 first_quarter PHA FDA related Application issues; pricing of prescription drugs Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2017-04-19T15:22:20.460000-04:00
1961914 BUCHANAN INGERSOLL & ROONEY PC f42d4c19-d27e-4a5b-9992-5045ae6fe709 1T BUCHANAN INGERSOLL & ROONEY PC 55291 PHARMACEUTICAL ASSOCIATES, INC. 2017 first_quarter PHA Strategy development and implementation of company's federal government relations initiatives. FDA process of enforcement of manufactured drugs. HOUSE OF REPRESENTATIVES,SENATE 50000   0 1 2017-04-19T15:38:39.947000-04:00
1961963 HANCE SCARBOROUGH b74cb7fd-987b-4365-ae8a-c54a7cd61f25 Q1 HANCE SCARBOROUGH 17443 ALLIANCE FOR PHARMACY COMPOUNDING 2017 first_quarter PHA Issues related to the regulation of pharmacy compounding. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2017-04-19T15:42:06.633000-04:00
1962007 BUCHANAN INGERSOLL & ROONEY PC 2be50893-2226-47dc-9e98-646456cd567d Q1 BUCHANAN INGERSOLL & ROONEY PC 55291 TONIX PHARMACEUTICALS HOLDING CORP. 2017 first_quarter PHA Federal funding related to clinical trials for military PTSD HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2017-04-19T15:46:34.180000-04:00
1962032 ASSOCIATION OF NATIONAL ADVERTISERS, INC. d69465ca-a5e3-4365-8bf3-951480ad9988 Q1 ASSOCIATION OF NATIONAL ADVERTISERS, INC. 4653 ASSOCIATION OF NATIONAL ADVERTISERS, INC. 2017 first_quarter PHA Proposals relating to the regulation of direct-to-consumer prescription drug advertising Federal Communications Commission (FCC),HOUSE OF REPRESENTATIVES,SENATE   430000 0 0 2017-04-19T15:46:40.603000-04:00
1962136 AKIN GUMP STRAUSS HAUER & FELD bd6d055d-8b1a-40a6-8073-aad16b355e2b Q1 AKIN GUMP STRAUSS HAUER & FELD 682 PHARMEDIUM SERVICES, LLC 2017 first_quarter PHA Drug Quality and Security Act, Pub. L. 113-54; FDA regulatory implementation of Section 503B of the Food, Drug and Cosmetic Act; FDA Pharmacy Compounding Advisory Committee; House & Senate Agriculture, FDA & Related Agency Appropriations bills. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2017-04-19T15:52:37.917000-04:00
1962243 KING & SPALDING LLP 5adb61f6-a43d-420c-889e-f902bc9f79cf Q1 KING & SPALDING LLP 21632 SUMITOMO PHARMA AMERICA (FORMERLY SUNOVION PHARMACEUTICALS, INC.) 2017 first_quarter PHA Issues related to inclusion of prescription drugs within Essential Health Benefit and mental health coverage expansion HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2017-04-19T15:59:42.447000-04:00
1962613 PRIME THERAPEUTICS 479c09d5-1517-40e5-beea-f41f4f6f03be Q1 PRIME THERAPEUTICS 400339576 PRIME THERAPEUTICS 2017 first_quarter PHA Generic drug user fee act - provisions to ensure greater market competition for generics. Biosimilar drug user fee act - ensuring greater competition in the biosimilar market. S.469/H.R.1245: Affordable and Safe Prescription Drug Importation Act. S.771/H.R.1776: Improving Access to Affordable Prescription Drugs Act - issues relating to ensuring a competitive drug marketplace. S.778:Prescription Drug Monitoring Act - issues related to dispensers access to PDMPs across state lines. HOUSE OF REPRESENTATIVES,SENATE   40000 0 0 2017-04-19T16:28:39.407000-04:00
1962728 NATIONAL ASSOCIATION FOR THE ADVANCEMENT OF COLORED PEOPLE 9057e537-5ee4-481c-ae4c-040b80a3084d Q1 NATIONAL ASSOCIATION FOR THE ADVANCEMENT OF COLORED PEOPLE 48975 NATIONAL ASSOCIATION FOR THE ADVANCEMENT OF COLORED PEOPLE 2017 first_quarter PHA Support maintaining ACA Patient Protections and Access to Prescription drugs Support S. 469 / HR 1245, the Affordable and Safe Prescription Drug Importation Act Support Klobuchar Amendment #178 to S. Con. 3 which established a deficit neutral fund relating to lower drug prices for Americans by importing prescription drugs from Canada. Support Wyden amendment #188 to S Con Res 3 creating a point of order against legislation that does not lower drug prices. Agriculture, Dept of (USDA),Bureau of Alcohol Tobacco Firearms & Explosives,Centers For Medicare and Medicaid Services (CMS),Consumer Financial Protection Bureau (CFPB),Education, Dept of,Election Assistance Commission (EAC),Environmental Protection Agency (EPA),Federal Communications Commission (FCC),Federal Motor Carrier Safety Administration,Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Justice, Dept of (DOJ),Labor, Dept of (DOL),Natl Park Service (NPS),Office of Management & Budget (OMB),Office of the Comptroller of the Currency (OCC),Securities & Exchange Commission (SEC),SENATE,Social Security Administration (SSA),Transportation, Dept of (DOT),Treasury, Dept of,White House Office   68750 0 0 2017-04-19T16:35:23.750000-04:00
1962786 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 9ffa2307-156d-4e6e-beff-88a9843e587e Q1 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 29403 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 2017 first_quarter PHA Pseudoephedrine Potential legislation to implement real-time, stop-sale electronic tracking system for sales of medications containing pseudoephedrine in order to preserve consumer access to the ingredient, common in popular cold and allergy medications (no bill number) and oppose prescription requirement (no bill number). Oral Contraceptives H.R. 421/S. 93 - Allowing Greater Access to Safe and Effective Contraception Act of 2017. Grants priority review of applications to switch oral contraceptive drugs from prescription to nonprescription (over-the-counter) status; all sections. Over-the-counter (OTC) medicines; Manufacturing and importation of OTC drugs; Mandatory recall authority of the FDA; Rx-to-OTC Switch Supporting a process within FDA that ensures clarity and timely outcomes for the FDA, applicants and stakeholders, as well as utilizing existing technologies to further streamline the prescription-to-nonprescription switch application process without changing the existing clear distinction between prescription and nonprescription medicines. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of   252000 0 0 2017-04-19T16:40:55.500000-04:00
1962824 COVINGTON & BURLING LLP 1cbf1771-5091-4d75-aeb8-1644e19fa54c Q1 COVINGTON & BURLING LLP 11195 CELGENE CORPORATION 2017 first_quarter PHA Expressing support for changes to the CREATES Act (S. 3056), Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051), Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act), and Affordable and Safe Prescription Drug Importation Act (S. 469). HOUSE OF REPRESENTATIVES,SENATE 70000   0 0 2017-04-19T16:43:14.797000-04:00
1962982 AMERICAN FEDERATION OF STATE, COUNTY AND MUNICIPAL EMPLOYEES ce8bb03a-a0bc-484a-ac81-498d36492ae2 Q1 AMERICAN FEDERATION OF STATE, COUNTY AND MUNICIPAL EMPLOYEES 2321 AMERICAN FEDERATION OF STATE COUNTY AND MUNICIPAL EMPLOYEES 2017 first_quarter PHA HR 1628- American Health Care Act of 2017 S 771, HR 1776- Improving Access to Affordable Prescription Drugs Act HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE,White House Office   630000 0 0 2017-04-19T16:52:32.533000-04:00
1963011 RUBIN AND RUDMAN LLP 93ac099b-4eb2-4a7f-b813-cc6335ee74dc Q1 RUBIN AND RUDMAN LLP 400942719 BLINK HEALTH LTD (A BERMUDA LIMITED COMPANY) 2017 first_quarter PHA Advocate for client before members of the U.S. House of Representatives, U.S. Senate, and staffs to each, with respect to market based solutions to drug pricing and chain pharmacy barriers to generic pharmaceutical price reduction. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2017-04-19T16:53:43.797000-04:00
1963411 NOVO NORDISK INC. 95b5ffaf-6148-4b6c-9b67-6ee08ba629e1 1A NOVO NORDISK INC. 284790 NOVO NORDISK INC. 2017 first_quarter PHA Issues related to Prescription Drug User Fee Act VI; issues related to 340B program; H.R. 1245/S. 469 Affordable and Safe Prescription Drug Importation Act Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),SENATE   1270000 0 0 2017-04-19T17:32:04-04:00
1963547 HIGHMARK, INC. ae777d99-f805-4c5c-9470-9a8b1403aa68 Q1 HIGHMARK, INC. 18238 HIGHMARK INC 2017 first_quarter PHA Opioid Epidemic, Rx costs, transparency, formulary limitations HOUSE OF REPRESENTATIVES,SENATE   350000 0 0 2017-04-19T17:49:45.977000-04:00
1963597 ML STRATEGIES, LLC 03592d9a-b10f-4634-aefc-e368b36cc7bf Q1 ML STRATEGIES, LLC 25603 THE CAMPAIGN FOR SUSTAINABLE RX PRICING 2017 first_quarter PHA Issues related to prescription drug pricing; S. 3056 - CREATES Act HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2017-04-19T17:55:17.070000-04:00
1963778 THORSEN FRENCH ADVOCACY LLC 0545a2c3-9954-4ba7-a628-f1d9d03adf18 Q1 THORSEN FRENCH ADVOCACY LLC 400599826 CARDINAL HEALTH, INC. 2017 first_quarter PHA Issues related to prescription drug abuse. Issues related to pharmaceutical market value. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2017-04-19T18:30:58.077000-04:00
1963787 NATIONAL NURSES UNITED b97a2a34-4a0c-449e-8151-3e4d64908676 Q1 NATIONAL NURSES UNITED 40021153 NATIONAL NURSES UNITED 2017 first_quarter PHA S.469 - Affordable and Safe Prescription Drug Importation Act, to allow prescription drug importation HOUSE OF REPRESENTATIVES,Occupational Safety & Health Administration (OSHA),SENATE   50000 0 0 2017-04-19T18:34:07.170000-04:00
1963829 THORSEN FRENCH ADVOCACY LLC cddbe6ae-2979-484e-b6a8-a004ec0fa3dc Q1 THORSEN FRENCH ADVOCACY LLC 400599826 HEALTHCARE DISTRIBUTION ALLIANCE 2017 first_quarter PHA General issues related to prescription drug abuse. Issues related to pharmaceutical market value. Prescription drug importation. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2017-04-19T18:42:37.560000-04:00
1963915 KOUNTOUPES DENHAM CARR & REID, LLC 5a9949cf-63cf-4937-abbf-ca634139ce8b Q1 KOUNTOUPES DENHAM CARR & REID, LLC 320918 ASSOCIATION FOR ACCESSIBLE MEDICINES (FORMERLY - GENERIC PHARMACEUTICAL ASSN) 2017 first_quarter PHA Policy matters related to generic pharmaceuticals and biosimilars, including reauthorization of the Generic Drug User Fee Agreement, reauthorization of the Biosimilar User Fee Agreement, H.R. 2051, The FAST Generic Act of 2017, S.771/H.R. 1776, Improving Access to Affordable Drugs, and changes to the Risk Evaluation and Mitigation Strategies (REMS) program. Issues related to drug takeback and opioid addition. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2017-04-19T19:08:54.357000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 2982.005ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API